Andrew Lees (vaccinologist)
Dr. Andrew Lees | |
|---|---|
| Born | February 1953 (age 72) Massachusetts, United States |
| Education | Harvey Mudd College, Johns Hopkins University |
| Occupation | Vaccine chemist |
| Known for | Developing the CDAP conjugation method |
| Medical career | |
| Profession | Vaccinologist |
| Field | Biochemistry |
| Institutions | Fina Biosolutions |
Andrew Lees (born February 1953 in Massachusetts, United States) is an American vaccine chemist known for developing the CDAP conjugation method, used in vaccines manufactured by GlaxoSmithKline (Streptococcus pneumoniae, Neisseria meningitidis ) and conjugate vaccines currently in clinical development by the Serum Institute of India and Chengdu Institute of Biological Products. Currently, Andrew Lees holds 25 patents in the area of conjugate vaccines.